SG174575A1 - Photochromic ophthalmic systems that selectively filter specific blue light wavelengths - Google Patents
Photochromic ophthalmic systems that selectively filter specific blue light wavelengths Download PDFInfo
- Publication number
- SG174575A1 SG174575A1 SG2011069739A SG2011069739A SG174575A1 SG 174575 A1 SG174575 A1 SG 174575A1 SG 2011069739 A SG2011069739 A SG 2011069739A SG 2011069739 A SG2011069739 A SG 2011069739A SG 174575 A1 SG174575 A1 SG 174575A1
- Authority
- SG
- Singapore
- Prior art keywords
- blue
- component
- wavelengths
- light
- blocking
- Prior art date
Links
- 230000000903 blocking effect Effects 0.000 claims description 96
- 230000005540 biological transmission Effects 0.000 claims description 93
- 230000035945 sensitivity Effects 0.000 claims description 37
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 claims description 29
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 claims description 28
- 238000001429 visible spectrum Methods 0.000 claims description 18
- 230000004913 activation Effects 0.000 claims description 16
- 239000004904 UV filter Substances 0.000 claims description 13
- 150000004032 porphyrins Chemical class 0.000 claims description 11
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 8
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims description 5
- DEMILCWIXNOUPD-UHFFFAOYSA-N C1(=C(C(=CC(=C1)C)C)C1=C2C=CC(C(=C3C=CC(=C(C=4C=CC(=C(C5=CC=C1N5)C5=C(C=C(C=C5C)C)C)N4)C4=C(C=C(C=C4C)C)C)N3)C3=C(C=C(C=C3C)C)C)=N2)C.[Mg] Chemical compound C1(=C(C(=CC(=C1)C)C)C1=C2C=CC(C(=C3C=CC(=C(C=4C=CC(=C(C5=CC=C1N5)C5=C(C=C(C=C5C)C)C)N4)C4=C(C=C(C=C4C)C)C)N3)C3=C(C=C(C=C3C)C)C)=N2)C.[Mg] DEMILCWIXNOUPD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000975 dye Substances 0.000 description 150
- 238000000576 coating method Methods 0.000 description 86
- 239000011248 coating agent Substances 0.000 description 67
- 239000010410 layer Substances 0.000 description 67
- 239000010408 film Substances 0.000 description 62
- 239000000463 material Substances 0.000 description 52
- 230000003287 optical effect Effects 0.000 description 52
- 230000003667 anti-reflective effect Effects 0.000 description 51
- 239000000758 substrate Substances 0.000 description 48
- 230000004438 eyesight Effects 0.000 description 39
- 238000000034 method Methods 0.000 description 35
- 238000002834 transmittance Methods 0.000 description 30
- 230000004456 color vision Effects 0.000 description 24
- 239000000049 pigment Substances 0.000 description 24
- 238000001228 spectrum Methods 0.000 description 24
- 238000001914 filtration Methods 0.000 description 23
- 229920000515 polycarbonate Polymers 0.000 description 23
- 239000004417 polycarbonate Substances 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 210000001747 pupil Anatomy 0.000 description 21
- 210000001525 retina Anatomy 0.000 description 21
- 230000004296 scotopic vision Effects 0.000 description 20
- 230000003595 spectral effect Effects 0.000 description 19
- 238000000411 transmission spectrum Methods 0.000 description 19
- 238000010521 absorption reaction Methods 0.000 description 17
- 230000006870 function Effects 0.000 description 16
- 230000004310 photopic vision Effects 0.000 description 16
- 230000027288 circadian rhythm Effects 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 14
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 14
- 230000004224 protection Effects 0.000 description 13
- 239000002987 primer (paints) Substances 0.000 description 11
- 230000000007 visual effect Effects 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 230000002207 retinal effect Effects 0.000 description 10
- 206010034972 Photosensitivity reaction Diseases 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 208000002780 macular degeneration Diseases 0.000 description 9
- 208000007578 phototoxic dermatitis Diseases 0.000 description 9
- 231100000018 phototoxicity Toxicity 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 206010064930 age-related macular degeneration Diseases 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000004907 flux Effects 0.000 description 8
- 230000007935 neutral effect Effects 0.000 description 8
- 231100000760 phototoxic Toxicity 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 description 7
- 230000030833 cell death Effects 0.000 description 7
- 239000003086 colorant Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 description 7
- 229940068984 polyvinyl alcohol Drugs 0.000 description 7
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 239000006117 anti-reflective coating Substances 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000003278 mimic effect Effects 0.000 description 6
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- 241000287127 Passeridae Species 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 208000002177 Cataract Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000010339 dilation Effects 0.000 description 4
- 239000001761 ethyl methyl cellulose Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000004297 night vision Effects 0.000 description 4
- 230000010344 pupil dilation Effects 0.000 description 4
- 238000000985 reflectance spectrum Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000002060 circadian Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 108091008695 photoreceptors Proteins 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000002310 reflectometry Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 230000004304 visual acuity Effects 0.000 description 3
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 238000004383 yellowing Methods 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 206010002945 Aphakia Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 235000017274 Diospyros sandwicensis Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 241000976924 Inca Species 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 206010069652 Retinal phototoxicity Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 201000005969 Uveal melanoma Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001720 action spectrum Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 210000001775 bruch membrane Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 230000005895 circadian behavior Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000040 eye damage Toxicity 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012788 optical film Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000005316 response function Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000000790 retinal pigment Substances 0.000 description 1
- 210000000880 retinal rod photoreceptor cell Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000006120 scratch resistant coating Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000001040 synthetic pigment Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/10—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
- G02C7/102—Photochromic filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1659—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having variable absorption coefficient for electromagnetic radiation, e.g. photochromic lenses
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B5/00—Optical elements other than lenses
- G02B5/20—Filters
- G02B5/22—Absorbing filters
- G02B5/23—Photochromic filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/16965—Lens includes ultraviolet absorber
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
- G02C2202/16—Laminated or compound lenses
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Ophthalmology & Optometry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electromagnetism (AREA)
- Eyeglasses (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optical Filters (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16322709P | 2009-03-25 | 2009-03-25 | |
| PCT/US2010/028680 WO2010111499A1 (en) | 2009-03-25 | 2010-03-25 | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG174575A1 true SG174575A1 (en) | 2011-10-28 |
Family
ID=42781510
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011069739A SG174575A1 (en) | 2009-03-25 | 2010-03-25 | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths |
| SG10201401064WA SG10201401064WA (en) | 2009-03-25 | 2010-03-25 | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201401064WA SG10201401064WA (en) | 2009-03-25 | 2010-03-25 | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2411862A4 (ja) |
| JP (2) | JP2012522270A (ja) |
| KR (1) | KR101768548B1 (ja) |
| CN (2) | CN102439512B (ja) |
| AU (1) | AU2010229849B2 (ja) |
| BR (1) | BRPI1013300A2 (ja) |
| CA (1) | CA2756668A1 (ja) |
| HK (2) | HK1165016A1 (ja) |
| SG (2) | SG174575A1 (ja) |
| WO (1) | WO2010111499A1 (ja) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120075577A1 (en) | 2006-03-20 | 2012-03-29 | Ishak Andrew W | High performance selective light wavelength filtering providing improved contrast sensitivity |
| US8882267B2 (en) | 2006-03-20 | 2014-11-11 | High Performance Optics, Inc. | High energy visible light filter systems with yellowness index values |
| US8113651B2 (en) | 2006-03-20 | 2012-02-14 | High Performance Optics, Inc. | High performance corneal inlay |
| US9377569B2 (en) | 2006-03-20 | 2016-06-28 | High Performance Optics, Inc. | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths |
| US8770749B2 (en) | 2010-04-15 | 2014-07-08 | Oakley, Inc. | Eyewear with chroma enhancement |
| US9134547B2 (en) | 2011-10-20 | 2015-09-15 | Oakley, Inc. | Eyewear with chroma enhancement |
| US10359552B2 (en) | 2011-01-17 | 2019-07-23 | University Of Utah Research Foundation | Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles |
| US9764157B2 (en) | 2011-01-17 | 2017-09-19 | University Of Utah Research Foundation | Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles |
| US9606277B2 (en) | 2011-01-17 | 2017-03-28 | University Of Utah Research Foundation | Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cycles |
| JP5969194B2 (ja) * | 2011-10-31 | 2016-08-17 | Hoya株式会社 | 眼鏡レンズの製造方法 |
| JP5969195B2 (ja) * | 2011-10-31 | 2016-08-17 | Hoya株式会社 | 眼鏡レンズの製造方法 |
| EP3561580A1 (en) * | 2011-10-31 | 2019-10-30 | Hoya Corporation | Eyeglass lens |
| EP2602655B1 (en) * | 2011-12-08 | 2024-04-03 | Essilor International | Ophthalmic filter |
| EP2602654B1 (en) * | 2011-12-08 | 2023-04-19 | Essilor International | Ophthalmic filter |
| EP2602653B1 (en) | 2011-12-08 | 2020-09-16 | Essilor International | Method of determining the configuration of an ophthalmic filter |
| WO2013169987A1 (en) | 2012-05-10 | 2013-11-14 | Oakley, Inc. | Eyewear with laminated functional layers |
| EP2901184A4 (en) * | 2012-09-26 | 2015-11-18 | 8797625 Canada Inc | MULTILAYER OPTICAL INTERFERENCE FILTER |
| FR2996930B1 (fr) * | 2012-10-11 | 2017-11-24 | Essilor Int | Lentille ophtalmique photochromique |
| JP2014097054A (ja) * | 2012-10-17 | 2014-05-29 | Menicon Co Ltd | 細胞取扱容器 |
| ES2686681T3 (es) * | 2013-03-01 | 2018-10-19 | Essilor International | Sistema óptico de control de la miopía |
| US9798163B2 (en) | 2013-05-05 | 2017-10-24 | High Performance Optics, Inc. | Selective wavelength filtering with reduced overall light transmission |
| GB201315836D0 (en) * | 2013-09-05 | 2013-10-23 | Polyphotonix Ltd | Medical apparatus and method |
| ITBO20130525A1 (it) * | 2013-09-25 | 2015-03-26 | Luxottica Srl | Lente per occhiali da sole |
| WO2015073933A1 (en) | 2013-11-15 | 2015-05-21 | University Of Utah Research Foundation | Nanoparticle light filtering method and apparatus |
| US10234608B2 (en) | 2013-11-15 | 2019-03-19 | University Of Utah Research Foundation | Nanoparticle light filtering method and apparatus |
| US9575335B1 (en) | 2014-01-10 | 2017-02-21 | Oakley, Inc. | Eyewear with chroma enhancement for specific activities |
| US9683102B2 (en) | 2014-05-05 | 2017-06-20 | Frontier Scientific, Inc. | Photo-stable and thermally-stable dye compounds for selective blue light filtered optic |
| US10901125B2 (en) | 2014-05-23 | 2021-01-26 | Eyesafe, Llc | Light emission reducing compounds for electronic devices |
| WO2016077431A2 (en) | 2014-11-13 | 2016-05-19 | Oakley, Inc. | Variable light attenuation eyewear with color enhancement |
| US10642087B2 (en) | 2014-05-23 | 2020-05-05 | Eyesafe, Llc | Light emission reducing compounds for electronic devices |
| TWI554803B (zh) * | 2014-11-25 | 2016-10-21 | Anti - blue contact lens method | |
| EP3045940A1 (en) * | 2014-12-31 | 2016-07-20 | Essilor International (Compagnie Generale D'optique) | Ophthalmic lens comprising an anti-reflective coating designed for scotopic conditions |
| CN106154366A (zh) * | 2015-04-24 | 2016-11-23 | 宣茂科技股份有限公司 | 滤蓝光光学膜片及其制造方法 |
| CN104808355B (zh) * | 2015-04-27 | 2017-05-24 | 宁波远志立方能源科技有限公司 | 一种防紫外光、衍射光和蓝光型隐形眼镜 |
| CN106543372A (zh) * | 2015-09-18 | 2017-03-29 | 鸿富锦精密工业（深圳）有限公司 | 眼用镜片材料、眼用镜片及人工晶状体 |
| EP3371647A1 (en) * | 2015-11-06 | 2018-09-12 | Essilor International | Optical article cutting blue light |
| CN105455946B (zh) * | 2015-11-24 | 2017-05-03 | 京东方科技集团股份有限公司 | 保护装置、保护方法、可穿戴设备和显示装置 |
| ES2927849T3 (es) | 2015-11-25 | 2022-11-11 | Jins Holdings Inc | Elemento óptico |
| EP3394665A1 (en) * | 2015-12-22 | 2018-10-31 | Essilor International | Method and ophtalmic element for stimulating a non-visual physiological effect |
| US10191305B2 (en) * | 2015-12-30 | 2019-01-29 | Signet Armorlite, Inc. | Ophthalmic lens |
| ES2964693T3 (es) | 2016-03-31 | 2024-04-09 | Hoya Lens Thailand Ltd | Lente de gafas y gafas |
| WO2017175873A1 (ja) * | 2016-04-07 | 2017-10-12 | 株式会社坪田ラボ | やせるめがね |
| WO2018025561A1 (ja) | 2016-08-04 | 2018-02-08 | イリスコミュニケーション株式会社 | 光学素子作製方法及び光学素子、並びに、色調整プログラム及び色調整装置 |
| CA3035431A1 (en) * | 2016-08-30 | 2018-03-08 | Hue.Ai, LLC | Optical device for enhancing human color vision |
| EP3296799B1 (en) * | 2016-09-20 | 2024-05-22 | Essilor International | Optical article with blue cut, high uv cut and high clarity |
| EP3296775A1 (en) * | 2016-09-20 | 2018-03-21 | Essilor International | Apparatuses and methods for blue-cut lenses |
| ES2941899T3 (es) | 2016-11-23 | 2023-05-26 | Essilor Int | Composición con funcionalidad epoxi que protege tintes de la fotodegradación y recubrimientos curados preparados a partir de la misma |
| EP3327488B1 (en) * | 2016-11-23 | 2021-01-06 | Essilor International | Optical article comprising a dye resistant to photo-degradation |
| CN108613022A (zh) * | 2016-12-12 | 2018-10-02 | 佛山市香港科技大学Led-Fpd工程技术研究开发中心 | 低蓝光危害led光源及其制作方法和灯具 |
| CN106772744B (zh) * | 2017-03-24 | 2018-11-27 | 杭州灯之塔科技有限公司 | 一种色平衡的防蓝光镜片、眼镜、装备及其制造方法 |
| WO2018181911A1 (ja) * | 2017-03-31 | 2018-10-04 | ホヤ レンズ タイランド リミテッド | 眼鏡レンズ |
| CA3072541A1 (en) * | 2017-08-09 | 2019-02-14 | University Of Utah Research Foundation | Methods, systems, and apparatus for reducing the frequency and/or severity of photophobic responses or for modulating circadian cycles |
| CN111417892B (zh) | 2017-10-20 | 2022-09-13 | 陆逊梯卡有限公司 | 具有可变透射镜片的眼镜 |
| US11112622B2 (en) | 2018-02-01 | 2021-09-07 | Luxottica S.R.L. | Eyewear and lenses with multiple molded lens components |
| WO2019156143A1 (ja) * | 2018-02-09 | 2019-08-15 | 三井化学株式会社 | レンズおよびレンズの製造方法 |
| JP7350280B2 (ja) * | 2018-09-27 | 2023-09-26 | 東海光学株式会社 | プラスチック眼鏡レンズ及び眼鏡 |
| US11592701B2 (en) | 2018-11-28 | 2023-02-28 | Eyesafe Inc. | Backlight unit with emission modification |
| US11126033B2 (en) | 2018-11-28 | 2021-09-21 | Eyesafe Inc. | Backlight unit with emission modification |
| US11810532B2 (en) | 2018-11-28 | 2023-11-07 | Eyesafe Inc. | Systems for monitoring and regulating harmful blue light exposure from digital devices |
| US11347099B2 (en) | 2018-11-28 | 2022-05-31 | Eyesafe Inc. | Light management filter and related software |
| US12019315B2 (en) | 2019-05-24 | 2024-06-25 | Lululemon Athletica Canada Inc. | Optical device for enhancing the well-being of a wearer |
| US10971660B2 (en) | 2019-08-09 | 2021-04-06 | Eyesafe Inc. | White LED light source and method of making same |
| US12055797B2 (en) * | 2019-10-31 | 2024-08-06 | Menicon Singapore Pte Ltd. | Contact lens with selective wavelength transmittance |
| TWI779275B (zh) * | 2020-03-31 | 2022-10-01 | 望隼科技股份有限公司 | 防藍光隱形眼鏡、其組合物及製備方法 |
| CN112539922B (zh) * | 2020-12-08 | 2023-12-05 | Oppo广东移动通信有限公司 | 头戴式显示设备及蓝光测试系统、蓝光测试方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL300132A (ja) * | 1962-11-19 | |||
| US4043637A (en) * | 1973-06-15 | 1977-08-23 | American Optical Corporation | Photochromic light valve |
| US5177509A (en) * | 1987-02-26 | 1993-01-05 | Suntiger, Inc. | Ultraviolet radiation and blue light blocking polarizing lens |
| JPH08254603A (ja) * | 1995-03-15 | 1996-10-01 | Mizunokaku Megane Kk | ハーフ調光プラスチックレンズおよびその製造方法 |
| WO2000029877A1 (de) * | 1998-11-16 | 2000-05-25 | Optische Werke G. Rodenstock | Neutralfarbener grauer photochromer kunststoffgegenstand |
| DE10026717A1 (de) * | 2000-05-30 | 2001-12-13 | Rodenstock Optik G | Photochromer Kunststoffgegenstand mit permanent gesteigertem Kontrast |
| US20040070726A1 (en) * | 2000-11-03 | 2004-04-15 | Andrew Ishak | Waterman's sunglass lens |
| US6641261B2 (en) * | 2001-10-06 | 2003-11-04 | Stryker Corporation | Lens for vision enhancement |
| US6863848B2 (en) * | 2002-08-30 | 2005-03-08 | Signet Armorlite, Inc. | Methods for preparing composite photochromic ophthalmic lenses |
| US7166357B2 (en) * | 2003-03-20 | 2007-01-23 | Transitions Optical, Inc. | Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation |
| US6926405B2 (en) * | 2003-06-06 | 2005-08-09 | Younger Mfg. Co. | Eyewear lens having selective spectral response |
| US7275822B2 (en) * | 2004-03-18 | 2007-10-02 | Essilor International (Compagnie Generale D'optique) | Progressive addition lenses with adjusted image magnification |
| CA2564921C (en) * | 2004-04-30 | 2015-03-24 | Advanced Medical Optics, Inc. | Ophthalmic devices having a highly selective violet light transmissive filter and related methods |
| CN1961041A (zh) * | 2004-05-27 | 2007-05-09 | 帝人化成株式会社 | 眼镜镜片 |
| US7701641B2 (en) * | 2006-03-20 | 2010-04-20 | Ophthonix, Inc. | Materials and methods for producing lenses |
| US8113651B2 (en) * | 2006-03-20 | 2012-02-14 | High Performance Optics, Inc. | High performance corneal inlay |
| US8360574B2 (en) * | 2006-03-20 | 2013-01-29 | High Performance Optics, Inc. | High performance selective light wavelength filtering providing improved contrast sensitivity |
| JP5475458B2 (ja) * | 2006-11-28 | 2014-04-16 | ハイ・パフォーマンス・オプティクス・インコーポレーテッド | 改良型コントラスト感度を提供する高性能選択型光波長フィルタリング |
-
2010
- 2010-03-25 CN CN201080022639.XA patent/CN102439512B/zh not_active Expired - Fee Related
- 2010-03-25 BR BRPI1013300A patent/BRPI1013300A2/pt active Search and Examination
- 2010-03-25 AU AU2010229849A patent/AU2010229849B2/en not_active Ceased
- 2010-03-25 EP EP10756850.3A patent/EP2411862A4/en not_active Withdrawn
- 2010-03-25 CN CN201410641454.7A patent/CN104360495B/zh not_active Expired - Fee Related
- 2010-03-25 CA CA2756668A patent/CA2756668A1/en not_active Abandoned
- 2010-03-25 JP JP2012502251A patent/JP2012522270A/ja active Pending
- 2010-03-25 SG SG2011069739A patent/SG174575A1/en unknown
- 2010-03-25 SG SG10201401064WA patent/SG10201401064WA/en unknown
- 2010-03-25 WO PCT/US2010/028680 patent/WO2010111499A1/en active Application Filing
- 2010-03-25 KR KR1020117024951A patent/KR101768548B1/ko active IP Right Grant
-
2012
- 2012-06-11 HK HK12105669.5A patent/HK1165016A1/xx not_active IP Right Cessation
-
2015
- 2015-01-15 JP JP2015006193A patent/JP2015135495A/ja active Pending
- 2015-08-14 HK HK15107876.7A patent/HK1207426A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2411862A1 (en) | 2012-02-01 |
| SG10201401064WA (en) | 2014-07-30 |
| AU2010229849B2 (en) | 2015-06-11 |
| HK1165016A1 (en) | 2012-09-28 |
| CN102439512B (zh) | 2014-12-10 |
| CN102439512A (zh) | 2012-05-02 |
| BRPI1013300A2 (pt) | 2018-06-19 |
| AU2010229849A1 (en) | 2011-11-10 |
| CN104360495A (zh) | 2015-02-18 |
| CN104360495B (zh) | 2016-09-14 |
| HK1207426A1 (en) | 2016-01-29 |
| KR20120059448A (ko) | 2012-06-08 |
| EP2411862A4 (en) | 2014-07-16 |
| JP2015135495A (ja) | 2015-07-27 |
| WO2010111499A1 (en) | 2010-09-30 |
| CA2756668A1 (en) | 2010-09-30 |
| JP2012522270A (ja) | 2012-09-20 |
| KR101768548B1 (ko) | 2017-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11774783B2 (en) | High performance selective light wavelength filtering providing improved contrast sensitivity | |
| US11701315B2 (en) | High energy visible light filter systems with yellowness index values | |
| US9377569B2 (en) | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths | |
| AU2010229849B2 (en) | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths | |
| AU2007325483B2 (en) | High performance selective light wavelength filtering providing improved contrast sensitivity | |
| US8360574B2 (en) | High performance selective light wavelength filtering providing improved contrast sensitivity | |
| US8113651B2 (en) | High performance corneal inlay | |
| CN111292615B (zh) | 提供改进的对比灵敏度的高性能选择性光波长过滤 | |
| WO2008106449A1 (en) | High performance corneal inlay | |
| CA2924278C (en) | High performance selective light wavelength filtering providing improved contrast sensitivity |